1 Followers
24 Following
trendinghealthcarenews

trendinghealthcarenews

Medical Marijuana Market 2020 Trends, Size Analysis, Share, Leading Companies

Medical Marijuana Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Medical Marijuana Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.

Industry Synopsis:

Global Medical Marijuana Industry is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023. Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions.

Marijuana consists of chemical components cannabinoids, which can be used as medicine to treat the symptoms caused by illness. Medical marijuana plant or extract of the plant is used for the treatment. The increasing number of chronic diseases, rising acceptance of medical marijuana in healthcare and increasing research and development activities are the major factors driving the growth of the global medical marijuana market. Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market. For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.

The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.

Top Players:

The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.

Segmentation:

The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.

On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS). Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).

The route of administration segment has been further divided into oral, topical, inhalation and sublingual. The topical segment has been classified into ointments, lotions, creams, gels, and poultice.

The market, by distribution channel, has been segmented into dispensaries and online platforms.

Industry Updates:

In January 2019, it has been announced by the Arkansans Department of Health that the patients who are approved for purchasing medical; marijuana will receive patient cards by February 2019.

In January 2019, it has been announced that within next few days residents in Ohio will be able to purchase marijuana for medical purposes.

In January 2019, Trulieve, Florida's largest and first medical marijuana provider, has signed a deal to bring high-end edible marijuana products to Florida and will soon be made available for the registered medical marijuana patients in the form of cannabis chocolates, granola bars, honey, fruit leather, olive oil and more.

Medical Marijuana Market - Regional Analysis:

The market in the Americas is expected to dominate the global medical marijuana market during the forecast period owing to the increasing prevalence of chronic diseases, increasing number of cannabinoid drug approvals by regulatory authorities, and increasing expenditure on research and development of medical marijuana. The European market is expected to be the second-largest due to the favorable policies implemented by government and regulatory authorities and increasing applications of marijuana in healthcare. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing number of mental disorders and increasing expenditure on healthcare research and development. The market in the Middle East & Africa is likely to account for the smallest share of the global medical marijuana market. The market growth in this region can be attributed to the rising acceptance of medical marijuana in the treatment of illness and favorable government policies.

Browse Complete 85 Pages Premium Research Report Enabled with Respective 30+ Tables and Figures at https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Related News

Sex Cord Gonadal Stromal Tumor Market

Bariatric Surgery Devices Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

https://www.marketresearchfuture.com/

Insulin Delivery Devices Market 2020 Trends, Size Analysis, Share, Leading Companies

Insulin Delivery Devices Market Size, Application and Trends Analysis By Type (Insulin Syringes, Pen, Insulin Pumps, Insulin Jet Injectors, Pen Needles), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales And Diabetes Clinics/ Centers), End User and Region, Forecast Till 2025

The Global Insulin Delivery Devices Market size is estimated to grow at a CAGR of 7.85% and expected to reach USD 21,804 Million by 2025, says Market Research Future (MRFR). Insulin, a glucose directing hormone, assumes a fundamental job in the whole treatment of diabetes. Insulin delivery frameworks help in infusing insulin into the greasy tissue under the skin. Factors, such as developing diabetic populace, innovative headways in insulin delivery systems, and favoring repayment arrangements, expanding mindfulness among shoppers on the accessibility of a few delivery devices and advancement of human insulin devices are relied upon to positively affect the insulin delivery devices market. However, the accessibility of oral insulin as an elective medication delivery technique is probably going to hamper the development of the insulin delivery devices market. Expanding awareness about diabetic consideration is among the drivers for the insulin delivery devices market.

Insulin delivery devices, including traditional syringes, without needle injectors, and auto and pen injectors, have been broadly used for the organization of insulin to treat type 1 diabetes issue. The worldwide market for insulin delivery devices has seen constantly expanding R&D. Following the outlined course, it is anticipated that an expanding commonness of hyperglycemia, developing selection of self-injectable devices, and rising FDA endorsements drive the market development. Be that as it may, the nearness of cross-defilement and expanding cost of top of the line items are assessed to limit the market development during the conjecture time frame

Medtronic Recalls MiniMed Insulin Pumps for Potential Cybersecurity Risks the FDA has distinguished this as a Class I review, the most genuine sort of review. Utilization of these devices may cause genuine wounds or demise the review portrayed in this notice is a similar one that was reported in the FDA Safety Communication from June 27, 2019. Different factors that are driving the worldwide Insulin delivery devices market are developing appropriation of self-injectable devices and expanding FDA endorsements for tranquilize delivery devices.

Insulin Delivery Devices Market Competitive Analysis:

Some of the major key players in the global insulin drug delivery devices market include Novo Nordisk A/S, Becton, Dickinson and Company, Medtronic PLC, Eli Lilly, Sanofi, Johnson and Johnson, Biocon Limited, Tandem Diabetes Care, Inc., B. Braun Melsungen AG, and F. Hoffmann-La Roche.

Insulin Delivery Devices Market Segmentation:

By type, the global insulin delivery devices market is segmented into

  • insulin syringes
  • pen
  • pumps
  • insulin jet injectors
  • pen needles

The pen segment is further sub-segmented into reusable

  • insulin pens
  • disposable insulin pens

The pumps segment is further sub-segmented into

  • external/tethered pumps
  • patch pumps

The pen segment comprises

  • standard pen needles
  • safety pen needles

By distribution channel, the global insulin delivery devices market is segmented into

  • hospital pharmacy
  • retail pharmacy
  • online sales
  • diabetes clinics/centers

Based on end user, the global insulin delivery devices market is segmented into

  • hospitals & clinics
  • home care
  • specialty centers

Insulin Delivery Devices Market Regional Analysis:

Regionally, the Insulin Delivery Devices Market is segmented into the Americas, Asia-Pacific, Europe, and Middle East & Africa. Of these, the Americas is foreseen to rule the worldwide insulin delivery devices market inferable from the rising mindfulness about the condition and high social insurance consumption. The area is relied upon to reach USD 21,804.56 million by 2025 at 7.85% CAGR from 2019 to 2025. The Americas represented the biggest provincial market inferable from the developing biotechnology industry, the expanding commonness of diabetes, and a well-created human services segment.

For example, according to the National Diabetes Statistics Report, 2017 distributed by National Center for Chronic Disease Prevention and Health Promotion 30.3 million individuals have diabetes which is 9.4% of the complete populace in the US. These elements are driving the insulin delivery devices market in the Americas. Europe represented the second-biggest market share in 2017 because of broad R&D for medicinal services, expanding subsidizing, and developing appropriation of the innovation inside the area.

Browse Full Research Reports At:  https://www.marketresearchfuture.com/reports/insulin-delivery-devices-market-851

 

Insulin Delivery Devices Market Industry News:

  • Valeritas Holdings, Inc. a therapeutic innovation organization and creator of the V-Go Wearable Insulin Delivery gadget, which utilizes its exclusive h-Patch™ innovation, reported positive information from its preclinical pharmacokinetic.
  • the organization reported an association with Tandem to create future insulin delivery frameworks. While last talks are yet continuous over “specialized execution of gadget combination and related business bolster exercises.

Non-Invasive Prenatal Testing (NIPT) Market Trends growth Share, Analysis, Global Industry Demand 2025

Market Research Future published a research report on Non-Invasive Prenatal Testing (NIPT) Market Research Report - Global Forecast till 2025. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.

 

According to MRFR analysis, the global (NIPT) Market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.

 

Non-Invasive Prenatal Testing (NIPT) Market Overview

 

NIPT plays an essential role in complex patient emergencies condition for monitoring the fetal growth and condition. These devices and procedures are used for applications. As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births. The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.

 

Segmentation

 

The global NIPT market has been segmented based on product type, techniques, application, and end user.

The market, based on product type, has been divided into devices, consumables, and others. The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others. The devices are likely to hold the maximum market share in the global NIPT market. Consumables are further segmented into assay kits & reagents, disposables, and others.

 

The global NIPT market on the basis of techniques has been segregated into biochemical screening tests and ultrasound detection.

 

On the basis of application, the global non-invasive prenatal testing market is segmented into trisomy microdeletion syndrome and others.

 

The end user segment of the market consists of diagnostic laboratories, hospitals, and research institutes. The diagnostic laboratories segment is expected to hold the largest share of the market as these centers are primary locations for patients receiving non-invasive prenatal testing.

 

Key Players

 

Some of the key players in the global NIPT market are Laboratory Corporation of America Holdings (US), Natera, Inc, Yourgene Health (UK), Centogene Holding AG [CENTOGENE AG ] (Germany), Agilent Technologies, Inc, Beijing Genomics Institute (China), General Electric Company [GE Healthcare] (US), Illumina, Inc, Perkinelmer, Inc, PhytoHealth Corporation (Taiwan), Tarsa Therapeutics, Inc, Thermo Fisher Scientific, Inc, and F Hoffman-La Roche Ltd.

 

Browse full report @ https://www.marketresearchfuture.com/reports/non-invasive-prenatal-testing-market-8371

 

Regional Analysis

 

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures. The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.

 

Related News

Hearing Aids Market size

 Pharmaceutical Excipients Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

https://www.marketresearchfuture.com/

Stem Cell Banking Market Analysis 2020 Outlook, Industry Trends, Key Players, Share

Market Research Future Published Stem Cell Banking Market report. Stem Cell Banking Market Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions.

Market Highlights

According to MRFR analysis, Stem Cell Banking Market analysis is expected to register a CAGR of 9.8% during the forecast period of 2019 to 2025 and is expected to reach USD 12,056.7 Million by 2025.

 

Stem cells (SC) are a class of undifferentiated biological cells of a multicellular organism that have the ability to produce indefinite cells of the same type, from which certain types of cells (proliferation and replication) can be produced by differentiation in the body through early life and growth. The stem has the potential to develop into several different cell types, from muscle cells to brain cells. Factors representing the growth of the market are rising use of therapeutic potential of stem cells, increasing investments in stem cell-based research, surging number of hematopoietic stem cell transplantation (HSCT) procedures, and growing newborn population. For instance, in August 2018, the Ministry of Science and Technology (MOST) of the Government of China published a draft of the “2019 Annual Project Application Guide” for the Stem Cell and Transformation Research pilot project. The government proposed investing 400 million yuan (around USD 56.4 million) to support stem cell research in China. On the other hand, high operational and storage costs and dearth of awareness about stem cell banking in developing and underdeveloped nations are anticipated to impede the market growth during the forecast period.

 

Segmentation

The Global Stem Cell Banking Market has been segmented based on cell type, bank type, and application.

Based on cell type, the market has been divided into umbilical cord stem cells, adult stem cells, and embryonic stem cells. The umbilical cord stem cells segment has been additionally categorized into cord blood, cord tissue, and placenta. The umbilical cord stem cells segment will hold the highest market share over the forecast period due to huge demand for umbilical cord blood in stem cell research. Scientists found that the umbilical cord is a rich source of stem cells and are collected from people of different biological traits.

 

On the basis of bank type, the global stem cell banking market has been classified into private banks, public banks, and hybrid banks. The private bank's segment would lead the market throughout the forecast period as it generates greater revenue, the cost to retrieve cord blood is free, and has complete ownership rights preserved by the donor. In addition, private banks have flexible collection sites and assured, and secured access offers a competitive advantage over public banks.

 

By application, the market has been bifurcated into thalassemia, cerebral palsy, diabetes, leukemia, autism, and others. The diabetes segment is likely to witness the fastest market growth due to the rising burden of diabetes mellitus (DM) across the world, thereby augmenting the demand for stem cells. For instance, as per statistics published by the International Diabetes Federation (IDF), in 2017, about 425 million adults were living with diabetes worldwide, which is anticipated to increase to 629 million by 2045.

 

Key Players

 

Some of the key players in the Global Stem Cell Banking Market are Americord Registry LLC (US), CBR Systems, Inc. (US), Cryo-Cell International, Inc. (US), Cordlife (Singapore), Cryo-Save AG (Netherlands), Smart Cells International Ltd. (UK), Global Cord Blood Corporation (Hong Kong), Celgene Corporation (US), BrainStorm Cell Therapeutics (US), and Regrow Biosciences Pvt. Ltd. (India).

 

Access Report Details @ https://www.marketresearchfuture.com/reports/stem-cell-banking-market-8441

 

Regional Analysis

 

The market has been divided by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The stem cell banking market in the Americas has further been divided into North America and Latin America, with the North American market divided into the US and Canada. The existence of key market participants and sophisticated healthcare infrastructure, expanding network of stem cell banking services, and continuous efforts by researchers to explore new therapeutic applications of cord blood cells in the US and Canada is assisting in the dominance of North America. The European stem cell banking market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The stem cell banking market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is likely to register the fastest market growth over the forecast period owing to surging elder population, increasing product launches, growing investments in R&D projects, and the presence of favorable regulatory policies coupled with commercialization opportunities

 

Related News

 

Radiopharmaceutical Market

 

Needles Market

 

About Market Research Future:

 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Lymphedema Treatment Market ShareTrends growth Share, Analysis, Global Industry Demand

Industry Report “Lymphedema Treatment Market Research Report — Global Forecast till 2025” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Lymphedema Treatment Market.

Lymphedema Treatment Market is estimated to grow with a CAGR of 4.0%.

Market Synopsis

The increasing prevalence of cancer is expected to drive the Global lymphedema treatment market by treatment.

The strong clinical pipeline is likely to boost the market growth. Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema — Lymfactin. Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema. The market potential of the drug is estimated to be around USD 650 Million.

Market Influencer

Increased research & development in the market is estimated to influence the commercialization in the market. The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.

Key Players

  • 3A Health Care (Italy)
  • Bio Compression Systems, Inc. (US)
  • Devon Medical Products (US)
  • HERANTIS PHARMA PLC (Finland)
  • Lohmann & Rauscher (Germany)
  • Mego Afek Ltd (US)
  • SIGVARIS (Switzerland)
  • Tactile Systems Technology Inc. (US)
  • Wright Therapy Products (BSN Medical) (Germany)

Segmentation

By Type

  • Primary Lymphedema is caused by the abnormal development of the lymph system. Symptoms may occur at birth or older age. The primary lymphedema segment is estimated to hold the least market share in 2018.
  • Secondary Lymphedema is caused by damage to the lymph system owing to cancer treatment involving surgery, radiation therapy, and others. A majority of the patients suffered from secondary lymphedema making this the leading segment in 2018.

By Affected Area

  • Lower Extremity: Lower extremity lymphedema involves the swelling of ankles, legs, and feet. This segment is estimated to hold a share of 0% in 2018.
  • Upper Extremity: Upper extremity lymphedema is one of the most poorly understood complications of the disease, making the segment to hold a share of 9.0% in the market in 2018.
  • Genitalia: This segment held the least share of the market in 2018.

GET FULL REPORT @ https://www.marketresearchfuture.com/reports/lymphedema-treatment-market-8440

Market Influencer

Increased research & development in the market is estimated to influence the commercialization in the market. The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.

Related News

Pseudomonas Aeruginosa Treatment Market

Behavioral Health Services Market

Behavioral Health Services Market Analysis Outlook 2025 By Top Manufactures Size

Behavioral Health Services Market Research Report - Global Forecast till 2025

Behavior health services provide services to patients with mental health disorders, substance abuse disorders, and other mental disorders. Behavioral health includes conditions such as depression, anxiety, substance abuse, and others. Around 83% people in the US are suffering from behavioral health issues. According to Japanese study around 298 people were suffering from various behavioral disorders in 2018. The growth of the global behavioral health services market is driven by various factors such as an increasing global geriatric population, rising prevalence of the depressive disorder, and poor fitness levels. However, high costs of treatment are expected to curb the growth of the global behavioral health services market.

 

 According to MRFR analysis, behavioral health services market overview is expected to register a CAGR of 3.4% during the forecast period of 2019 to 2025 and was valued at USD 146.3 Billion by 2025.

Segmentation

The Global Behavioral Health Services Market has been segmented based on services type, disorder type, and end user.

The market, based on services type, has been divided into inpatient hospital treatment, outpatient counseling, home-based treatment services, emergency mental health services, and others. The inpatient hospital treatment segment is likely to be the largest during the review period due to a growing aging population globally. Around 1.3 million Americans are diagnosed with various behavioral disorders every year. The outpatient counseling segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly population. 

The global behavioral health services market has been segmented on the basis of disorder type, into anxiety disorder, bipolar disorders, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder, and others. The anxiety disorder segment is expected to hold the majority share of the market. Rising prevalence of anxiety disorder in most commonly seen in US. Around 40 million adults are diagnosed with anxiety disorder every year. The bipolar disorder segment is expected to be the fastest-growing due to its rising prevalence globally. It was estimated that around 7 million people in US were suffering through bipolar disorder in 2018.

The end user segments of the market are providers, patients, and others. The providers segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and services.

 

Key Players

 

Some of the key players in the global Behavioral Health Services market are Acadia Healthcare (US), National Mentor Holdings Inc (US), Behavioral Health Services Inc (US), Ocean Mental Health Services Inc (US), The MENTOR Network (US), Universal Health Services, Inc (US), Behavioral Health Network, Inc (US), CareTech Holdings PLC (UK), Strategic Behavioral Health (US), North Range Behavioral Health (US), Pyramid Healthcare (US), Promises Behavioral Health (US), and others.

 

Regional Analysis

 

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of behavioral disorders and rising per capita healthcare expenditure. The behavioral health services market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European behavioral health services market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The behavioral health services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of depression disorder and raising awareness about the behavioral health services methods, the market in Asia-Pacific is expected to be the fastest-growing. The behavioral health services market in the Middle East & Africa has been divided into the Middle East and Africa.

 

Get full report @ https://www.marketresearchfuture.com/reports/behavioral-health-services-market-8433

 

Related News

 

Sex Cord Gonadal Stromal Tumor Market

 

Bariatric Surgery Devices Market

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Smart Inhalers Market Regional Insights and Global Industry Trends By 2025

Smart Inhalers Market Size, Growth and Trends Analysis By Type (Dry Powder Inhaler and Metered Dose Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease and others), Key Players and Region (Americas, Europe, Asia-Pacific and Middle East and Africa), Forecast to 2025

Smart Inhalers Market size and share is anticipated to reach USD 4.72 billion at a CAGR of 45% throughout the forecast period (2019-2025). Smart Inhalers are respiratory inhalers equipped with a digital sensor that tracks the data, such as the dosage timing, and monitors the use of the inhaler while scheduling the next dosage as well. Smart Inhalers Market is expected to witness significant growth due to rising prevalence of asthma & COPD worldwide. Increasing population becoming susceptible to indoor air pollutants worldwide and Moreover, improved adherence rate driven by increasing patient’s preference to use digitalized medical devices for monitoring daily medication doses fosters the growth of the Smart Inhalers Market.

Also, increased collaboration deeds between pharmaceutical companies and to promote technological advancements are contributing to market growth. Increased focus on advancement in treatment methods, R&D programs, online marketing strategies incorporated by key players in pharmaceutical and biotechnological industries are some of the major trends observed in the market.

It is a new-age digital technology designed to empower patients, care contributors, researchers, and physicians related to respiratory diseases through objective and accurate medication monitoring and reminders. Alerts for the daily dosage are generated via Bluetooth. Smart inhalers have been successfully improving patient outcomes while reducing the significant financial costs associated with suboptimal medication adherence. This makes smart inhalers the next big thing in the respiratory care segment.

On the other hand, high costs associated with the smart inhalers and COPD & asthma treatments, limited availability of smart inhalers, and misinterpretation of information are some of the major factors obstructing the growth of the Smart Inhalers Market Companies. Key pharmaceutical companies are adopting digital technology for improved disease management for asthma and COPD and for improved effectivity of medicines. Wide range of benefits, including reducing financial costs associated with suboptimal medication adherence to enhanced efficacy of medicines, makes smart inhalers most preferred and popular in the respiratory care segment.

leading players include

 

AstraZeneca (UK), Adherium (New Zealand), Cohero Health (US), Gecko Health Innovations, Inc (US), GlaxoSmithKline (UK), Propeller Health (US), and Inspiro Medical (Israel), among others.

Highly competitive by nature, the smart inhalers market appears to be fragmented due to the presence of market titans in the market. To maintain their market positions. Key companies are venturing into new regions and countries with rapid expansion plans. Top players are substantially investing in R&D and clinical trials to accelerate product development and innovations and to cut down production costs.

Global Smart Inhalers Market Segmentation:

Smart Inhalers Market is segmented by

Type

Application

End User

Region

By Type, the Smart Inhalers Market is segmented into

Dry Powder Inhaler

Metered-dose Inhaler

By Application, the Smart Inhalers Market is segmented into

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

others

By End-user, the Smart Inhalers Market is segmented into

Hospitals & Clinics

Research Institute

Respiratory Care Centers

others

Regional Insights:

By Regions Global Smart Inhalers Market is segmented into

Asia Pacific

North America

Europe

Rest-of-the-World

North America leads the global smart inhalers market, accounting for the largest market share.  Increased awareness about asthma and COPD treatment and the increased adoption of smart inhalers help the region to cut the largest revenue share, globally. Moreover, large asthma and COPD patient population in the region foster the regional market growth.

The smart inhalers market in the European region took the second-largest position holding 31.89% market share, in 2018.  The presence of a number of noteworthy players such as Novartis, AstraZeneca, and Boehringer Ingelheim drive the regional market growth. Moreover, the high adoption of smart inhalers in hospitals and patients in European countries is expected to boost the growth in the regional market throughout the assessment period.

The Asia pacific smart inhalers market is emerging as a promising market, globally. Factors, such as the spreading awareness about the benefits that smart inhalers can provide in managing asthma and COPD, influence the market growth in the region. Besides, improvement in healthcare infrastructure with an increased budget for healthcare expenses would fuel the APAC smart inhalers market. The region is expected to grow rapidly throughout the forecast duration, with China being the major revenue contributor.

Browse Complete Report https://www.marketresearchfuture.com/reports/smart-inhalers-market-2117

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

 

Nuclear Imaging Devices Market 2020 | Global Industry Analysis By Size, Share, Segments

Market Research Future (MRFR) publishes periodic market research reports Nuclear Imaging Devices Market Research Report - Global Forecast till 2024 on niche and emerging technologies.

 

The global nuclear imaging devices market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.

The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.

Segmentation

The global Nuclear Imaging Devices Market size is segmented based on technology, application, end user, and region.

The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.

Based on application, the market is segmented into oncology, cardiology, neurology, and others.

Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.

The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.

Intended Audience

  • Medical devices companies
  • Government and private laboratories
  • Research and development (R&D) companies
  • Research laboratories
  • Market research and consulting service providers

Global Nuclear Imaging Devices Market Research Report: Information by Technology (PET, SPECT (Hybrid SPECT Systems and Standalone SPECT Systems) and Planar Scintigraphy)), Application (Oncology, Cardiology, Neurology and others), End User (Hospitals, Diagnostic Imaging Centers and others) and Region - Global Forecast till 2024. For more info visit @https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014

Key Players

Some of the key players in the global nuclear imaging devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

https://www.marketresearchfuture.com

Cancer Registry Software Market Size, Analysis, Share and Outlook To 202| COVID-19 Pandemic

Market Research Future published a research report on Cancer Registry Software Market Research Report — Global Forecast till 2024. Report gives a clear picture of current market scenario which includes past and estimated future market size.

The global cancer registry software market is expected to grow significantly over the forecast period. The market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period.

Increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are positively affecting market growth.

Segmentation

By type, the market has been segmented into integrated software and standalone software.

Based on the deployment model, the market has been segmented into cloud-based models and on-premise models.

On the basis of the database type, the market has been segmented into commercial databases and public databases.

By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.

The cancer registry software market, by end-user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.

Table of Content

Chapter 6. Global Cancer Registry Software Market, By Type

6.1 Introduction

6.2 Integrated Software

Market Estimates & Forecast, By Region, 2019–2024

Market Estimates & Forecast, By Country, 2019–2024

6.3 Standalone Software

Market Estimates & Forecast, By Region, 2019–2024

Continued…

Global Cancer Registry Software Market Research Report By Type, End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) — Forecast till 2024, For more info visit

https://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852

Intended Audience

· Software companies

· Contract research organizations

· Academic and research institutes

· Government associations

Related News

Craniomaxillofacial (CMF) Devices Market Research Report — Global Forecast till 2024

Nuclear Imaging Devices Market Research Report — Global Forecast till 2024

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

https://www.marketresearchfuture.com

 

Surgical Snare Market Analysis 2020 Global Trends, Size, Opportunities

The Global Surgical Snare Market size is expected to grow at an approximate CAGR of 4.4% during the forecast period, 2018–2023. A surgical snare is a wire hoop use to tighten polyps or small tumors for severing, especially in body cavities. Surgical snares are extensively utilized in endoscopy. From the past few years, the market has grown with a rapid pace owing to the increasing number of endoscopy procedures, growing geriatric population, and rising healthcare expenditure.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), about 30 to 40 percent of people in the United States get an H. pylori infection which is the cause of peptic ulcers. However, factors such as low per capita income and lack of skilled workforce are estimated to restraint the market growth. World Health Organization (WHO) estimates that based on a threshold of 4.4 skilled health professionals per 1000 population, the needs-based shortage of health-care workers globally would be about 17.4 million of which almost 2.6 million are doctors and over 9 million are nurses and midwives.

Segmentation

The global surgical snare market is segmented based on usability, application, end user, and region.

On the basis of usability, the global surgical snare market is segmented into reusable and single use. By application, the global surgical snare market by application is categorized into laparoscopy, endoscopy, cystoscopy, otoscopy, laryngoscopy, neuroendoscopy, and others. By end-user, the global surgical snare market is categorized into hospitals & clinics, ambulatory surgical centers, and others.

Regional Analysis

The Americas dominates the global market owing to the rising occurrence of diseases, high healthcare expenditure and well-developed healthcare infrastructure. In the United States, the annual spending on GI diseases is estimated to be nearly USD 140 billion. Following similar trends, Europe stands second in the market. Rising geriatric population is estimated to fuel the market.

Browse Full Research Reports At: https://www.marketresearchfuture.com/reports/surgical-snare-market-7842

Asia-Pacific was the fastest growing region for the global surgical snare market in 2017. Factors such as increasing innovation and awareness about the available treatment. On the other hand, the Middle East and Africa holds the least share in the global surgical snare market owing to the presence of poor economies and low per capita income, especially within the African region. Most of the market share within this region is estimated to be held by the Middle East.

Brows More Healthcare Related Market Research Reports:

Respiratory Care Devices Market

Medical Automation Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Opioids Market Size Industry Analysis 2020 Global Trends, Size, Opportunities

Market Research Future (MRFR) publishes periodic market research report on Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2023

Leading Market Players

Sanofi SA (France), Pfizer Inc. (US), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Allergan Inc. (US), Purdue Pharma L.P. (US), West-Ward Pharmaceuticals Corporation (Jordan), Sun Pharmaceutical Industries Ltd (India), Egalet Corporation (US), Janssen Global Services, LLC (US), Vertice Pharma LLC (UK), Mallinckrodt (Surrey), and others.

Opioids Market Overview

The Opioids Market by types is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.

Segmentation Analysis

The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.

Table of Content

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing Use Of Opioids For Disease Condition Causing Chronic Pains Such As Cancers, Arthritis, Lower Back Pain, And Fibromyalgia

4.2.2 Favorable Reimbursement Policies For Palliative Care In Developed Regions

4.2.3 Substantial Rise In Road Accidents, Trauma, And Surgical Procedures

4.3 Restraints

4.3.1 Rising Addiction And Death Cases Due To Overdose Of Opioid 26

4.4 Opportunities

4.4.1 Reconsideration Of Prescribing Opioid Analgesics Due To Rising Awareness About Opioids Misuse, Abuse, And Overdose Has Prompted Many Stakeholders

List of Tables

TABLE 1 MARKET SYNOPSIS

TABLE 2 PRIMARY INTERVIEWS

TABLE 3 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2015–2023 (USD MILLION)

TABLE 4 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 2015–2023 (USD MILLION)

TABLE 5 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2015–2023 (USD MILLION)

Continued…

COLLECT DETAILED INFORMATION OF THE REPORT @ https://www.marketresearchfuture.com/reports/opioids-market-7626

Intended Audience

  • Pharmaceutical Companies
  • Research Institutes
  • Hospitals
  • Academic Institutes

This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global opioids market.

Related News

Sex Cord Gonadal Stromal Tumor Market

Bariatric Surgery Devices Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

https://www.marketresearchfuture.com/

 

Epigenetics Market Analysis 2020 | Share Analysis, Market Value, Size Estimation

Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.

 

The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023.

 

Market Dynamics:

 

Oncology Segment Is Expected To Be The Largest Driver Of Market Growth

 

The growing incidence of cancer is the prime drivers of the market. According to W.H.O. cancer was responsible for 8.8 million deaths in 2015, indenting nearly 1 in 6 patient’s deaths. Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015. According to the estimates of the Centers for Disease Control and Prevention, almost 1.5 million people are diagnosed with cancer per year in the U.S. alone, resulting in more than five lakh deaths.

 

Technology Development Is Expected To Drive A Faster Market Adoption

 

The development of highly sensitive and selective tests, instrumentation and a concurrent rise in computational power is driving a broad adoption. The advancements such as the development of DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, ligases, and other protein-modifying enzymes has generated tremendous enthusiasm and concurrent faster market adoption.

 

The growing government support for biotechnology and growing partnership between academia and industry is another driver of growth. Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market. Other technological developments include automation, advances in PCR technology, strategic and cross-functional nature of the molecular diagnostic technology and others.

High Cost Of Installation And Maintenance And Nascent Stage Of Technology May Hamper The Market Growth

 

The prime market constraints include prohibitive costs of molecular diagnostics, the high cost of manufacturing, consolidated nature of the market has put a premium on the price of the epigenetics products, nascent stage of technology and high power of firms relative to buyers.

 

Segments:

 

To generate a bird’s view of the global Epigenetics Market by products, the report is segmented based on instruments, consumables, applications, technology, end users, and regions.

 

Based on instruments, the market comprises of NGS, spectrometer, PCR, software solutions and others.

 

Based on consumables, the market comprises of kit, enzymes, reagent, and others.

Based on application, the market comprises of oncology, developmental biology, drug discovery, cardiology, immunology, and others

.

Based on technology, the market comprises of methylation, histone modification, and others.

 

Based on end users the market is segmented into academia and research, pharmaceutical and biotechnology industry and others.

 

Based on the regions, the market is segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world.

 

Regional analysis:

 

North America led by the U.S. accounts for the most significant market share of the market, owing to faster technology uptake, the large biotech sector of the U.S., the presence of large advanced players, growing prevalence of cancer.

 

Europe led by Germany, U.K., and France accounts for the second-largest and second fastest market during the forecasted period. Asia led by Japan and supported by China, South Korea, and India is anticipated to be the fastest growing market.

 

The Middle East and Africa market will expand at a slower rate on account of the weak industry landscape and low demand due to weak economic conditions.

 

Key Vendors:

 

Some of the dominant vendors operating in the report are Bio-Rad (US), Illumina (US), QIAGEN (Netherlands), Thermo Fisher (US), Active Motif (US), Diagenode (Belgium), Agilent (US), Merck Millipore (US), Abcam (UK), New England Biolabs (US), PerkinElmer (US), Zymo Research (US), and others.

 

Access Report @

 https://www.marketresearchfuture.com/upcoming-reports/epigenetics-market-6161

 

Intended Audience

  • Pharmaceutical companies
  • Biotechnological institutes
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers

Related News

Sex Cord Gonadal Stromal Tumor Market

 

Bariatric Surgery Devices Market

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

illumina dna sequencing market share Analysis 2020 Global Trends, Size, Opportunities, Sales Revenue

Global DNA sequencing market is expected to exhibit a strong 17.64% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global DNA sequencing market is mainly driven by the growing prevalence of cancer and the growing awareness of the assistance DNA sequencing can provide in diagnosing it, the growing geriatric population and the growing prevalence of neurodegenerative conditions, and the growing awareness about DNA sequencing.

 

Cancer is a major healthcare concern in modern times and has become a major disease to defeat for leading players in the global healthcare sector. Early diagnosis of cancer has been shown to be vital in beating the disease, with early diagnosis and screening significantly improving the chances of patients of beating the disease in the long run. DNA sequencing can be of help in this matter, as DNA sequencing allows patients to learn if they have a predetermined tendency to develop cancer. Genetic predisposition towards cancer can be diagnosed through DNA sequencing, and can help physicians stay on top of the disease even before it develops. The growing burden of cancer on the global healthcare system is likely to be a major driver for the global illumina dna sequencing market

 

The increasing prevalence of neurodegenerative diseases is also likely to be a major driver for the global DNA sequencing market over the forecast period. Neurodegenerative diseases often have a genetic component, which can be isolated and identified through DNA sequencing. This allows physicians to offer early, precautionary and preventive treatments to combat neurodegenerative diseases, as well as being able to manage the progression of the disease in case it does develop. This is likely to be a key driver for the global DNA sequencing market over the forecast period.

 

DNA Sequencing Market Competitive Analysis:

Leading players in the global DNA sequencing market include Beckman Coulter, Bayer Corporation, Myriad Genetics, Siemens Healthineers GmbH, General Electric Company, Hamilton Thorne Biosciences, Thermo Fisher Scientific, Tecan, Eppendorf, Illumina, Life Technologies, Deep Genomics Inc., Johnson & Johnson, Pacific Biosciences, Koninklijke Philips N.V., Oxford Nanopore Technologies, Genia Corporation, Agilent Technologies Inc., Roche Holdings AG, and PerkinElmer.

In November 2019, researchers in Germany found a way of illuminating the unseen regions of DNA sequences, called short tandem repeats (STRs). The method combines CRISPR-Cas technology with nanopore sequencing and stem cells in order to observe STRs, which have previously been inaccessible. This could lead to technologies that more accurately and quickly predict diseases.

 

In November 2019, Illumina Inc. opened a new training center in the University of Maryland BioPark in Baltimore.

 

DNA Sequencing Market Segmentation:

 

The global DNA sequencing market has been segmented on basis of type, product, technology, application, and end-users.

 

On the basis of type, the DNA sequencing market is segmented into instruments and consumables services and workflow products.

 

Based on products, the DNA Sequencing Market is segmented into sequencing services and sequencing instruments and consumables. Sequencing instruments and consumables are further sub-segmented into two types, namely, sequencing instruments and consumables by product type and by platform type. Sequencing instruments and consumables, by product type, are further sub-segmented into consumables and instruments, whereas sequencing instruments and consumables, by platform type, are further sub-segmented into NGS, sanger, bioinformatics, sample prep kits, and reagents.

 

On the basis of technology, the DNA sequencing market is further segmented into semiconductor sequencing, pyrosequencing, sequencing by synthesis, single-molecule real-time sequencing (SMRT), sequencing by ligation (SBL), and other technologies.

 

On the basis of application, the DNA sequencing market is further segmented into diagnostics, agriculture and animal research, biomarker discovery, personalized medicine, drug discovery, and other applications.

 

Based on end-user, the DNA sequencing market is segmented into research centers and government institutes and academia, biotechnology and pharmaceutical companies, clinics and hospitals, and other end-users.

 

DNA Sequencing Market Regional Analysis:

 

North America holds the dominant share in the global DNA sequencing market, followed by Europe. The strong presence of leading players in the North America market has been a major driver for the DNA sequencing market in the region.

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/dna-sequencing-market-5774

Related News

Mucormycosis Market

Pulse Oximeters Market

 

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

https://www.marketresearchfuture.com

Blood Glucose Monitoring Market 2023 Analysis Overview by Top Companies Analysis

Worldwide Blood Glucose Monitoring Market Research Report — Global Forecast till 2023 Size, Growth, Emerging Technologies, Demand, Competitive, Regional Landscape with Global Forecast To 2023

Global continuous glucose monitoring market players is expected to grow at a CAGR of 7.1% during the forecast period 2017–2023.

Leading Market Players

Some of key the players in the market are Abbott Laboratories (U.S.), Arkay, Inc. (U.S.), Bayer Healthcare AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Goldsite Diagnostics Inc., GlySure Ltd (U.K), Sphere Medical Holding plc. (U.K), Dexcom, Inc. (U.S.), and LifeScan, Inc. (U.S.).

Market Overview

Blood Glucose Monitoring can be defined as the process of testing the diabetes level in the blood. The devices help to identify the blood glucose level within the specific target range. The monitoring devices help to track the progression of treatment and observe the effects of medication on blood sugar level. The surging prevalence of diabetes is likely to favour the market growth in the coming years.

The blood glucose monitoring market is considered one of the rapidly expanding markets, mainly due to the surging growth in urbanization, leading to soaring incidences of obesity. Developments in technology, increased investment in R&D activities, and surging awareness regarding these devices are some of the primary growth stimulants of the market.

Segmental Analysis

By mode of product type, continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, flash glucose monitoring devices, and others.

By mode of application, type 1 diabetes, type 2 diabetes, and others.Type-I and type-II diabetes are further sub-segmented into pediatrics and adult. The rising prevalence of type-II diabetes is fueling the growth of the use of blood glucose monitoring system.

By mode of end-users, hospitals, diagnostic centers, research centers, clinics,and home care diagnostics. Among these, the homecare segment is considered to dominate the global market owing to an increased diabetic population coupled with the growing preference for minimally invasive technologies which can be used at home.

Intended Audience

  • Blood Glucose Monitoring Devices Suppliers
  • Blood Glucose Monitoring Devices Manufacturers
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Academic Medical Institutes and Universities
  • Hospitals and Clinics
  • Homecare Diagnostics

Industry Updates

January 03, 2019: A team of researchers at KTH Royal Institute of Technology, Stockholm have recently developed a promising alternativefor people with diabetes. A microneedle patch with 50 times smaller than the needles used in the CGM systems, this glucose monitor is a reliable and comfortable blood-sugar monitoring system which has proven to be virtually painless and more accurate.

Regional Insights

The American region is estimated to command the largest market share and is likely to maintain its pole position in the coming years. The growth has been ascribed to the surging incidences of obesity, physical inactivity, and unhealthy diet. As per the D, in 2015 the incidences of diagnosed as well as undiagnosed diabetes population were 30.3 million of the total US population

The European region is likely to occupy the second spot in the global market due to environmental pollutants, sociological deprivation, and psychological factors

The Asia Pacific region is estimated to expand at the fastest rate due to surging geriatric population, changing lifestyle, and urbanization. The rapidly developing healthcare technology, increasing expenditure on healthcare, high concentration of prominent companies, and surging R&D activities are some of the top factors likely to offer the market a boom. The surging demand for new treatment technologies especially in the economies like South Korea and India is further estimated to contribute to the market growth. As per the International diabetes federation, there were approximately 69.1 million suffering from diabetes.

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/blood-glucose-monitoring-market-557

Table of Content

  1. Report Prologue
  2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

  1. Research End Userology

 

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

  1. Market Dynamics

 

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Continued…..

Browse other healthcare-related reports

population health management industry report

Home Healthcare Market Information

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Laser Therapy Devices Market Analysis Size 2020| Global Industry Share, Competitive LandscapeLaser Therapy Devices Market Analysis Size 2020| Global Industry Share, Competitive Landscape

Laser Therapy Market Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023

Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global Laser Therapy Devices Market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old population complements this factor since the elderly populace is more prone to acquiring diseases such as arthritis and cataract which induces additional demand for laser therapy.

Heightened demand for minimally-invasive and non-invasive procedures is a major drive behind the growth of the market. Consumers are highly inclined towards medical procedures which do not involve incisions and cuts. Additionally, laser therapy is extensively used in dermatology and cosmetology. Skyrocketing demand for aesthetics also encourages the growth of the global laser therapy market. Use of laser therapy in dentistry is also a key market influencer. On the contrary, the growth of the global laser therapy market might be impeded by high costs associated with laser therapy.

Segmentation

 

The global laser therapy market has been segmented based on type and application.

 

By type, the global laser therapy market has been segmented into diode lasers, solid state lasers, gas lasers, dye lasers, and others.

 

By application, the global laser therapy market has been segmented into surgery, dermatology and aesthetics, dental, and others. The surgery segment is further segmented into urology, ophthalmology, and others.

 

Regional Analysis

 

The Americas, Asia Pacific (APAC), Europe, and The Middle East & Africa (MEA) are the key markets for laser therapy.

 

The Americas is at the forefront of the global laser therapy market. A robust healthcare sector, high expenditure on healthcare, and widespread prevalence of chronic diseases in the region spur the growth of the global laser therapy market. In addition, the regions propensity to incorporate new and advanced technologies in the healthcare sector acts as a plus for the growth of the market. Other factors boosting the growth of the Americas market include growth in a number of aged populace and the presence of key players in the region.

 

Europe holds the second most significant share of the global laser therapy market. The region invests substantially in R&D activities which coupled with the availability of funds creates a conducive environment for the growth of the laser therapy market in Europe. A broad base of the patient population, well-developed healthcare sector, and high government support contribute to the growth of the market.

 

 

APAC is the fastest growing market for laser therapy. Expanding patient pool, development of the healthcare sector in the developing countries of China and India present growth opportunities to the APAC market. Also, increased affordability due to rising disposable income, government endeavors towards the modernization of the healthcare sector are other boosting factors.

 

 

The MEA market is likely to exhibit the least share of the global laser therapy market. Limited availability of healthcare facilities, lack of funds, and lack of awareness and dearth of skilled medical professionals constrain the growth of the market over the forecast period, especially in the Africa region. The Middle East accounts for the foremost share of the MEA market and is driven by high healthcare expenditure in the region.

Access Report Details @ https://www.marketresearchfuture.com/reports/laser-therapy-market-3812

 

Competitive Landscape

 

The key players in the global laser therapy market include Biolase Inc. (U.S.), Alma Lasers (Israel), Cutera (U.S.), IRIDEX Corp. (U.S.), Valeant (Canada), Coherent, Inc. (U.S.), and Angiodynamics, Inc. (U.S.).

 

Industry Updates

 

In December 2018, TRUMPF GmbH, a company involved in laser technology, announced the acquisition of Photonics GmbH from Philips. Through the acquisition, TRUMPF intends to expand its foothold in the growing markets in the photonics and digital products sectors.

 

Related news

 

Medical Tourism Market

Immunoassay Analyzers Market Share

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

https://www.marketresearchfuture.com

Immunoassay Analyzers Market Report, History and Forecast 2020,Share Analysis, Market Value

Market Research Future (MRFR) has launched a new release on the Clinical Immunoassay Analyzers Market. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period on the basis of the market’s historical growth trajectory and figure

Automated Immunoassay Analyzers Market overview

Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global Immunoassay Analyzers Market size is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimbursement policies may restrain this growth during the forecasted period.

Segmentation

  • On the basis of instruments :

The market is classified into immunofluorescence, chemiluminescence, ELISA, enzyme linked fluorescent system, multiplexed assay system, radioimmunoassay and others.

  • On the basis of application :

The market is segmented into infectious diseases, autoimmune diseases, AIDS, endocrinology, drug monitoring, cardiology, oncology, allergy testing and others.

  • On the basis of end users :

The market is categorized into hospitals, diagnostic laboratories, research institutes, and others.

Regional Analysis

The global immunoassay analyzer market is dominated by America, which is followed by Europe. Presence of huge diabetic and cancer population, large geriatric population, and well developed healthcare sector has driven this market’s growth in America. Europe immunoassay analyzer market is majorly driven by the presence of large number of pharmaceutical and biotechnological companies. Along with these, Asia Pacific also has the fastest growing immunoassay analyzer market due to rapidly developing economies with huge population base, mainly in India and China. However, the Middle East & Africa has the least market due to limited development in the healthcare sector.

Some of the major key player of this market are

  • F. Hoffmann-La Roche Ltd. (Switzerland),
  • Siemens Ltd. (Germany),
  • Abbott (US),
  • Beckman Coulter,
  • Ortho Clinical Diagnostics (US),
  • bioMérieux Private Limited (France),
  • Biokit S.A (Spain),
  • The Binding Site Group Ltd. (UK),
  • Immunodiagnostic Systems (UK),
  • Merck KGaA (US), and others.

Increasing prevalence of different types of chronic diseases is fueling the growth of this market. The global immunoassay analyzer market is a highly competitive market due to the presence of many small and medium companies. These companies are focusing on the development of new and advances devices, while some companies have adopted strategies of acquisitions and strategic alliances, this will consequently lead to this market’s growth.

Hoffmann-La Roche Ltd, a Swiss multinational healthcare company, operates under two division, which are diagnostics and pharmaceuticals. In 2016, the company launched the new cobas e 801 module, which will help hospitals and laboratories to meet the demand of diagnostic testing. Cobas e 602 is one of the most widely used devices of this company.

Access Report Details @ https://www.marketresearchfuture.com/reports/immunoassay-analyzers-market-1200

Browse other healthcare-related reports

Rickets Market Research Report – Global Forecast till 2023

Avascular Necrosis Market Research Report – Forecast to 2024

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

https://www.marketresearchfuture.com